TimesSquare Capital Management, LLC
Q2 2023 13F-HR Holdings
Net value change ($000)
+132,279
(1.9%)
New positions
14
Sold out positions
18
Turnover %
5.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| RPM | 54,254 | 1033.0% |
| TER | 43,760 | 137.8% |
| LSCC | 42,680 | NEW |
| STEVANATO GROUP S P A | 40,085 | NEW |
| REATA PHARMACEUTICALS INC | 34,824 | 11269.9% |
| IDXX | 23,819 | 46.4% |
| GFL | 20,420 | 35.2% |
| SVV | 18,961 | NEW |
| CSGP | 17,775 | 28.1% |
| ESTC | 16,967 | 58.0% |
Top Reduces (Value $000, Stocks/ETFs)
| SBAC | -47,203 | -67.5% |
| FMC | -40,183 | -100.0% |
| CASY | -37,158 | -100.0% |
| VAC | -24,185 | -49.1% |
| ASND | -22,867 | -25.0% |
| AR | -18,472 | -100.0% |
| ENTG | -17,650 | -46.7% |
| Prometheus Biosciences, Inc. | -17,606 | -100.0% |
| SM | -17,584 | -100.0% |
| IVERIC bio, Inc. | -17,513 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|